Triptolide suppresses the growth and metastasis of non-small cell lung cancer by inhibiting β-catenin-mediated epithelial–mesenchymal transition

Non-small cell lung cancer (NSCLC) is characterized by a high incidence of metastasis and poor survival. As epithelial–mesenchymal transition (EMT) is well recognized as a major factor initiating tumor metastasis, developing EMT inhibitor could be a feasible treatment for metastatic NSCLC. Recent st...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Qiu-di, Lei, Xue-ping, Zhong, Yi-hang, Chen, Min-shan, Ke, Yuan-yu, Li, Zhan, Chen, Jing, Huang, Li-juan, Zhang, Yu, Liang, Lu, Lin, Zhong-xiao, Liu, Qing, Li, Song-pei, Yu, Xi-yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379262/
https://www.ncbi.nlm.nih.gov/pubmed/33893396
http://dx.doi.org/10.1038/s41401-021-00657-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379262/
https://www.ncbi.nlm.nih.gov/pubmed/33893396
http://dx.doi.org/10.1038/s41401-021-00657-w

Ejemplares similares